Telemetry Investments’s Aratana Therapeutics, Inc. PETX Stock Holding History

Telemetry Investments’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$52K	–	86
2019 Q2	$52K	Buy	+10,000	New	+$44.9K	0.04%	79

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Telemetry Investments's PETX Position: Q3 2019 in Review

Telemetry Investments sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 10,000 shares — an estimated $52K sold.

Telemetry Investments first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $52K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Telemetry Investments reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Telemetry Investments sold 10,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $52K.
Telemetry Investments first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Telemetry Investments's Aratana Therapeutics, Inc. position peaked at $52K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Telemetry Investments's 13F filing for Q3 2019, filed 14 Nov 2019.